[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342166-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342166-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","patient-specific-prostate-tumour-growth-simulation-a-first-step-towards-the-digital-twin","Patient-specific prostate tumour growth simulation - a first step towards the digital twin","","Prostate cancer (PCa) is a major global health concern, and treatment choices increasingly rely on patient-specific imaging evidence. This work introduces a personalized PCa framework that integrates clinical MRI data—prostate and tumour geometry, initial cellular distribution, and vasculature—to build a whole-prostate model. Finite Element Method simulations couple tumour growth with oxygen transport and cellular processes (proliferation, differentiation, apoptosis). The approach further models PSA dynamics, uses multi-objective optimization to fit parameters for two patients, and validates predictions using MRI follow-ups from four patients. It forecasts tumour and prostate volume growth and serum PSA levels, supporting early digital-twin development.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/patient-specific-prostate-tumour-growth-simulation-a-first-step-towards-the-digital-twin/342166/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/patient-specific-prostate-tumour-growth-simulation-a-first-step-towards-the-digital-twin/342166.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data sources does the personalized model use?","Question",{"text":63,"@type":64},"The framework integrates clinical MRI information including prostate and tumour geometry, initial cell distribution, and the vasculature, enabling whole-prostate representation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is tumour growth predicted in the proposed framework?",{"text":68,"@type":64},"Tumour growth is simulated using the Finite Element Method, coupling tumour-growth dynamics with oxygen transport and cellular processes such as proliferation, differentiation, and apoptosis.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the method link simulation outputs to PSA measurements?",{"text":72,"@type":64},"It includes a simulation of PSA dynamics, allowing tumour growth to be evaluated through the patient’s PSA levels over time.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342166,1790519993,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Original Research PUBLISHED 30 October 2024  \nDOI 10.3389/fphys.2024.1421591  \nOPEN ACCESS  \nEDITED BY  \nHenggui Zhang, The University of Manchester, United Kingdom  \nREVIEWED BY  \nVasileios Vavourakis, University of Cyprus, Cyprus Xu Huang,  \nNanjing University of Science and Technology, China  \n*CORRESPONDENCE  \nMaría Ángeles Pérez,  angeles@unizar.es  \nRECEIVED 22 April 2024  \nACCEPTED 16 October 2024  \nPUBLISHED 30 October 2024  \nCITATION  \nPérez-Benito Á, García-Aznar JM,  \nGómez-Benito MJ and Pérez MÁ (2024) Patient-specific prostate tumour growth simulation: a first step towards the digital twin.  \nFront. Physiol. 15:1421591 .  \ndoi: 10.3389/fphys.2024.1421591  \nCOPYRIGHT  \n© 2024 Pérez-Benito, García-Aznar, Gómez-Benito and Pérez. This is an  \nopen-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nPatient-specific prostate tumour growth simulation: a first step towards the digital twin  \nÁngela Pérez-Benito, José Manuel García-Aznar , María José Gómez-Benito and María Ángeles Pérez*  \nMultiscale in Mechanical and Biological Engineering (M2BE), Aragon Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain  \nProstate cancer (PCa) is a major world-wide health concern. Current diagnostic methods involve Prostate-Specific Antigen (PSA) blood tests, biopsies, and Magnetic Resonance Imaging (MRI) to assess cancer aggressiveness and guide treatment decisions. MRI aligns with in silico medicine, as patient-specific image biomarkers can be obtained, contributing towards the development of digital twins for clinical practice. This work presents a novel framework to create a personalized PCa model by integrating clinical MRI data, such as the prostate and tumour geometry, the initial distribution of cells and the vasculature, so a full representation of the whole prostate is obtained. Ontop of the personalized model construction, our approach simulates and predicts temporal tumour growth in the prostate through the Finite Element Method, coupling the dynamics of tumour growth and the transport of oxygen, and incorporating cellular processes such as proliferation, differentiation, and apoptosis. In addition, our approach includes the simulation of the PSA dynamics, which allows to evaluate tumour growth through the PSA patient’s levels. To obtain the model parameters, a multi-objective optimization process is performed to adjust the best parameters for two patients simultaneously. This framework is validated by means of data from four patients with several MRI follow-ups. The diagnosis MRI allows the model creation and initialization, while subsequent MRI-based data provide additional information to validate computational predictions. The model predicts prostate and tumour volumes growth, along with serum PSA levels. This work represents a preliminary step towards the creation of digital twins for PCa patients, providing personalized insights into tumour growth.  \nKEYWORDS  \nprostate cancer, in-silico model, patient-specific, imaging biomarkers, computational oncology, finite element method (FEM)  \n1 Introduction  \nProstate cancer (PCa) is a major health concern world-wide, being the most common cancer and the third leading cause of cancer-related deaths in men after lung and colorectal cancers. Projections indicate that by 2040 in Europe, the incidence rate of PCa is expected to rise by 27.6%, with mortality increasing by 53.2%, according to the World Health Organization (WHO) .  \nThe routine methods employed for the diagnosis of the PCa generally include blood tests to measure the Prostate-Specific Antigen (PSA) level, d","cbCain2VAQSqSrC5","https://ap.wps.com/l/cbCain2VAQSqSrC5","pdf",80219618,22,"English","# 1 Introduction\n## Prostate cancer overview and diagnosis methods\n## Imaging and risk stratification (PSA, Gleason, PiRADs, mpMRI)\n## Treatment options and role of PSA\n# Key objectives of the proposed digital-twin framework","[{\"question\":\"What data sources does the personalized model use?\",\"answer\":\"The framework integrates clinical MRI information including prostate and tumour geometry, initial cell distribution, and the vasculature, enabling whole-prostate representation.\"},{\"question\":\"How is tumour growth predicted in the proposed framework?\",\"answer\":\"Tumour growth is simulated using the Finite Element Method, coupling tumour-growth dynamics with oxygen transport and cellular processes such as proliferation, differentiation, and apoptosis.\"},{\"question\":\"How does the method link simulation outputs to PSA measurements?\",\"answer\":\"It includes a simulation of PSA dynamics, allowing tumour growth to be evaluated through the patient’s PSA levels over time.\"}]","Patient-specific prostate tumour growth simulation - a first step towards the digital twin | PDF",1790045635,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c776456faf70ce489b0449b6bdab18dc.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/377210c49918b2f4ba24da6c4ec8b908.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43cd6572116eb619541960fe16bc1eda.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47af7b3477c15c153252f189768ae045.webp",980,1385]